Results for tag: "Suvorexant"

Suvorexant is a drug used to treat insomnia, a disorder of the central nervous system. It is a dual orexin receptor antagonist, meaning it blocks the action of orexin, a neurotransmitter that helps regulate wakefulness. Suvorexant is used to treat insomnia in adults, and is available in tablet form. It is taken once daily, usually at bedtime. Suvorexant is a relatively new drug, having been approved by the US Food and Drug Administration in 2014. It is the first and only dual orexin receptor antagonist approved for the treatment of insomnia. It is thought to be effective in treating insomnia due to its ability to reduce wakefulness and improve sleep quality. Some companies in the Suvorexant market include Merck & Co., Inc., Sunovion Pharmaceuticals, Inc., and Takeda Pharmaceuticals USA, Inc. Show Less Read more